Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c134 |
|---|---|
| Identifier | NCT07120152 |
| Trial Title | A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBD - Inflammatory Bowel Disease|RA - Rheumatoid Arthritis |
| Interventions | DRUG: Subcutaneous infliximab CT-P13 Remsima®SC |
Participant Information
| Sponsor | Erwin Dreesen |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2025-09-01 |
|---|---|
| Primary Completion Date | 2026-09-01 |
| Completion Date | 2027-03-01 |